Apretude, First Injectable PrEP, Gets FDA ApprovalIn mid-December 2021, the U.S. Food and Drug Administration (FDA) approved Apretude (cabotegravir) as the first injectable HIV preventive drug. Apretude is...reactions1comment
First Long-Acting HIV Injectable Cabenuva Receives FDA Approval The U.S. Food and Drug Administration (FDA) has approved Cabenuva (cabotegravir and rilpivirine) for the long-acting treatment of HIV. Cabenuva comes as...reactions8comments
2022-2030 World Health Organization Strategies for Ending HIVThe World Health Organization (WHO) has set new strategic directions to tackle HIV, among other health issues. These strategies were created to...reactions3comments
Getting Your Medicine With Mail DelaysAccess to medicine is important. Drug regimens are part of treating many health conditions, and delays in taking drugs can have serious...reactions2comments
COVID-19: Basics for the ImmunocompromisedFor those living with chronic health conditions, current news about the coronavirus (COVID-19) can be anxiety-inducing. We have questions and concerns about...reactionscomments
COVID-19: Tips to Reduce Your RiskWith all of the news circulating about the novel (new) coronavirus, it can be easy to feel overwhelmed or anxious. This is...reactionscomments
Increased Risk for Heart Disease and Stroke for People Living with HIVPeople living with HIV are at increased risk of developing cardiovascular conditions, according to a study published in the Journal of the...reactions4comments
FDA Makes Way for Experimental Drugs to Fight COVID-19On March 19, the U.S. Food and Drug Administration (FDA) approved the testing of two drugs, chloroquine (hydroxychloroquine) and remdesivir, to treat...reactionscomments
Take the Fatigue and Health Survey!The 2020 Fatigue and Health survey has now closed. Thank you for your interest! We are excited to share the results with...reactionscomments
